LYB
Lyondellbasell Indu-Cl A
NYSE · Chemicals
$55.10
+1.22 (+2.26%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 39.79B | 41.64B | 7.44B | 7.30B | 8.08B |
| Net Income | 1.35B | 1.27B | 1.07B | 974.42M | 1.18B |
| EPS | — | — | — | — | — |
| Profit Margin | 3.4% | 3.2% | 14.4% | 13.4% | 14.7% |
| Rev Growth | -4.4% | -4.4% | +19.8% | +6.8% | +9.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 4.19B | 4.19B | 1.21B | 1.19B | 1.20B |
| Total Equity | 4.68B | 4.68B | 6.99B | 7.44B | 7.52B |
| D/E Ratio | 0.89 | 0.89 | 0.17 | 0.16 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 3.64B | 3.62B | 1.31B | 1.33B | 1.49B |
| Free Cash Flow | — | — | 1.26B | 1.05B | 1.41B |